- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.06. | AZ's Truqap and Roche assay cleared for PTEN prostate cancer | ||
| 12.06. | UK offers meningitis jab to young people after outbreak | ||
| 12.06. | Pushy NHS chatbots 'can put patients off screening' | ||
| 12.06. | Patient information exposed in breach, says Novo Nordisk | ||
| 11.06. | UK approves Novo Nordisk's Wegovy pill | ||
| 11.06. | Takeda's TYK2 drug bests BMS's Sotyktu in psoriasis contest | ||
| 11.06. | J&J adds rare disease wAIHA to Imaavy's potential uses | ||
| 11.06. | Novartis gets win for another Avidity muscular dystrophy AOC | ||
| 11.06. | Basketball great Shaq fronts Lilly sleep apnoea campaign | ||
| 11.06. | Anthropic puts life sciences at heart of new AI model | ||
| 11.06. | SonoThera's $125m Series B heads recent biofinancings | ||
| 10.06. | Lilly wins new FDA approval for eczema drug Ebglyss | ||
| 10.06. | Bayer's asundexian starts EU review for ischaemic stroke | ||
| 10.06. | AbbVie's migraine drug cleared for migraine attacks on NHS | ||
| 10.06. | Cancer biotech Parabilis books record IPO, raising $670m | ||
| 10.06. | Sanofi abandons phase 3 trial of neurology drug riliprubart | ||
| 09.06. | Moderna jab on trial for cancer-causing syndrome | ||
| 09.06. | Jen Norton appointed market access leader at EVERSANA | ||
| 09.06. | Most doctors in UK think AI training is inadequate | ||
| 09.06. | ADA: AZ reveals oral GLP-1 data in obesity, diabetes | ||
| 09.06. | GSK pursues $10.6bn takeover of cancer biotech Nuvalent | ||
| 08.06. | J&J lights up $1bn offer for pan-KRAS developer Firefly | ||
| 08.06. | Incyte gobbles up Star's Vega haematology unit in $2bn deal | ||
| 08.06. | ADA: Lilly's weight-loss reveal, and wannabes display wares | ||
| 08.06. | Roche doubles down on BTK with $2.3bn Nurix deal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.